Please login to the form below

Not currently logged in
Email:
Password:

Bausch Lomb

This page shows the latest Bausch Lomb news and features for those working in and with pharma, biotech and healthcare.

Alexion expands in Ireland with new biofacility

Alexion expands in Ireland with new biofacility

Since the start of the year, Valeant subsidiary Bausch Lomb, Regeneron, Zimmer and ABEC have announced expansions to their Irish operations, while Horizon Pharma opened a global corporate headquarters in Dublin.

Latest news

More from news
Approximately 2 fully matching, plus 20 partially matching documents found.

Latest Intelligence

  • Deal Watch March 2016 Deal Watch March 2016

    Since 2011 it has made numerous acquisitions of companies, divisions and products (notably Medicis, Dendreon, Salix, Synergetics and Bausch &Lomb) expanding its therapeutic and geographical footprints and building a multi-billion ... Valeant's buying

  • Pharma deals during May 2014 Pharma deals during May 2014

    Allergan's presentation filed with the SEC claims that growth in the two largest Valeant acquisitions, Medicis and Bausch &Lomb, since Valeant acquired them, has been driven by price increases with

  • Pharma deals during February 2014 Pharma deals during February 2014

    PreCision focuses on the high quality medical dermatology market and provides further consolidation for Valeant in this field as it continues to integrate Bausch &Lomb into its ophthalmology business.

  • Deal Watch table for May 2013 Deal Watch table for May 2013

    Bausch &Lomb/ Valeant. Company acquisition. Ophthalmology business. 8, 700. Warner Chilcott/ Actavis.

  • Pharma deals during May 2013 Pharma deals during May 2013

    The next day BTG announced two deals worth $420m; then came Valeant's $8.7bn bid for Bausch &Lomb… and so on for the rest of the month and, with the ... With both parties hurting from the bust-up, Actavis went off and married Warner Chilcott for $8bn

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest appointments

  • BMS appoints three independent directors BMS appoints three independent directors

    Robert Bertolini brings strategic and operational leadership experience from Bausch &Lomb, where he recently served as president and chief financial officer prior to the company's sale to Valeant.

  • Bayer appoints president of Americas pharma business Bayer appoints president of Americas pharma business

    Prior to this, Dr Brunn was vice president of pharma, Asia-Pacific at Bausch &Lomb and served as global head of marketing at Basilea Pharmaceutica International, based in Basel, Switzerland.

  • Actinium appoints director of clinical operations Actinium appoints director of clinical operations

    Prior to this, Bergonio held a number of clinical research management positions at Bausch &Lomb, OSI Eyetech, Forest Laboratories, i3 Research and Kern McNeil.

  • Actavis looks to PepsiCo for CFO Actavis looks to PepsiCo for CFO

    Fuller and previously served on the board of directors of Bausch &Lomb, a healthcare company that was taken over by Valeant Pharmaceuticals in 2013.

  • New communications head for WebMD New communications head for WebMD

    Bausch Lomb's Adam Grossberg has joined WebMD in the newly created role of chief communications officer. ... Schlanger. Grossberg joins WebMD from Bausch Lomb where, as vice president of global communications, his responsibilities included public

More from appointments
Approximately 1 fully matching, plus 9 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Six Degrees Medical Consulting

Partnering with top global pharmaceutical companies, we push the boundaries to create meaningful, impactful and lasting learning opportunities. We leverage...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics